(S (NP (NP (DT A) (JJ statistical) (JJ volumetric) (NN model)) (, ,) (VP (VBG showing) (NP (NP (DT the) (NN probability) (NN map)) (PP (IN of) (NP (NP (JJ localized) (NN prostate) (NN cancer)) (PP (IN within) (NP (DT the) (NN host) (JJ anatomical) (NN structure))))))) (, ,)) (VP (VBZ has) (VP (VBN been) (VP (VBN developed) (PP (IN from) (NP (CD 90) (JJ optically-imaged) (JJ surgical) (NNS specimens)))))) (. .))
(S (NP (DT This) (NN master) (NN model)) (VP (VBZ permits) (NP (NP (NP (DT an) (JJ accurate) (NN characterization)) (PP (IN of) (NP (NN prostate) (NN cancer) (NN distribution) (NNS patterns)))) (CC and) (NP (DT an) (JJ atlas-informed) (NN biopsy) (VBG sampling) (NN strategy)))) (. .))
(S (NP (DT The) (NN model)) (VP (VBZ is) (VP (VBN constructed) (PP (IN by) (S (VP (VBG mapping) (NP (JJ individual) (NN prostate) (NNS models)) (PP (IN onto) (NP (NP (DT a) (NN site) (NN model)) (, ,) (ADVP (RB together) (PP (IN with) (NP (JJ localized) (NNS tumors))))))))))) (. .))
(S (NP (DT An) (JJ accurate) (JJ multi-object) (JJ non-rigid) (NN warping) (NN scheme)) (VP (VBZ is) (VP (VBN developed) (PP (VBN based) (PP (IN on) (NP (NP (DT a) (NN mixture)) (PP (IN of) (NP (JJ principal-axis) (NNS registrations)))))))) (. .))
(S (NP (PRP We)) (VP (VBP report) (NP (NP (PRP$ our) (NN evaluation) (CC and) (NN pilot) (NNS studies)) (PP (IN on) (NP (NP (NP (DT the) (NN effectiveness)) (PP (IN of) (NP (DT the) (NN method)))) (CC and) (NP (NP (PRP$ its) (NN application)) (PP (TO to) (S (VP (VBG optimizing) (NP (JJ needle) (NN biopsy) (NNS strategies)))))))))) (. .))
